A recent study indicates that people who discontinue blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle plans.
Findings released in a leading medical journal points out that while obese people frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People buying these medications need to be cognizant of the risk of fast weight regain when the treatment ends," warns expert Dr. Susan Jebb.
This pace of recovery suggests a return to starting weight in about a year and a half.
Analyzing Therapies
The study, which looked at dozens of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.
Scientists note that people who lose weight through lifestyle changes alone usually experience a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Nutrition scientists propose the mode of action of the injections accounts for the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement means hunger is no longer kept in check, making overeating much more probable."
A Chronic Disease?
Medical guidelines advise the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts say that, given the significant potential of relapse, the treatment might need to be ongoing.
This perspective is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," comparing it to managing diseases like high blood pressure.
User Testimonies
Individuals who have stopped the medication explain a intense return of appetite.
"It felt as if a switch that goes on and I was suddenly ravenous," described one woman.
This difficulty is worsened if patients have not developed lasting lifestyle or habit modifications during therapy.
Widespread Adoption
Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is higher among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Ultimately, researchers caution that while these medications are effective agents for weight loss, they are not a standalone solution and long-term success hinges on ongoing lifestyle changes.
